Pressreleases

Russell Finex: High Capacity Production of APIs

Sri Krishna Pharmaceuticals greatly increase production of APIs with Russell Finex screening solutions

Oncopeptides AB enters phase III clinical trials with Ygalo® (melflufen)

Oncopeptides AB recently announced that the first patient has been dosed in the pivotal phase III study OCEAN. The study is targeting Late-Stage Relapsed Refractory (RRMM) patients with Multiple Myeloma.

Setting a benchmark: Using rheology to define the performance of personal care products

Products, quality is often defined by a range of functional and sensory attributes, some of which may be easily measured - such as color - and others which may not. Visual or textural appearance and ease of application exemplify properties in this second category. Ultimately these attributes are assessed subjectively via user feedback, but relying on such information to guide formulation is somewhat impractical, particularly in the early stages of product development. Metrics that reliably correlate with product performance are therefore essential.

Using Taylor Dispersion Analysis to determine oligomeric state of insulin

Taylor dispersion analysis is an emerging biophysical characterization technique that offers unique benefits in the early stages of biopharmaceutical development – providing answers that established techniques cannot effectively handle.

Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017

Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London on 28th & 29th June 2017.

SHL to Host Webinar on Value of New Technology in Drug Delivery

SHL Group has announced that it will be holding a webinar discussing the value of new technologies in digital health and drug delivery systems on June 29.

Woodley Equipment Company is Exhibiting at DIA 2017 Annual Meeting

Woodley Equipment Company the Leading Global Provider of Equipment Solutions to the Clinical Trials Industry is Exhibiting Booth #1845 at DIA 2017 Annual Meeting.

Download NSF’s New Pharma APP – A Must-Have For Pharmaceutical Professionals

Whether you’re looking to stay up to date with what’s going on in an ever-changing pharmaceutical industry, want an easier and more convenient way to access our latest resources or require help with an immediate business issue, NSF have you covered.

Vetter and Microdermics Enter into a Strategic Cooperation Agreement

Vetter and Microdermics Enter into a Strategic Cooperation Agreement to Develop Innovative Microneedle Drug Delivery Systems.